{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:50:40Z","timestamp":1761540640813},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1990,5]]},"DOI":"10.1007\/bf01806350","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T19:38:43Z","timestamp":1119901123000},"page":"125-136","source":"Crossref","is-referenced-by-count":90,"title":["Long-term adjuvant tamoxifen therapy for breast cancer"],"prefix":"10.1007","volume":"15","author":[{"given":"V. Craig","family":"Jordan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01806350_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/jrf.0.0130101","volume":"13","author":"MJK Harper","year":"1967","unstructured":"Harper MJK, Walpole AL: A new derivative of triphenylethylene: Effect on implantation and mode of action in rats. J Reprod Fertil 13: 101\u2013119, 1967","journal-title":"J Reprod Fertil"},{"key":"BF01806350_CR2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1971.33","volume":"25","author":"MP Cole","year":"1971","unstructured":"Cole MP, Jones CTA, Todd IDH: A new antioestrogenic agent in late breast cancer: An early clinical appraisal of ICI46,474. Br J Cancer 25: 270\u2013275, 1971","journal-title":"Br J Cancer"},{"key":"BF01806350_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.1.5844.13","volume":"i","author":"HWC Ward","year":"1973","unstructured":"Ward HWC: Antioestrogen therapy for breast cancer: A trial of tamoxifen at two dose levels. Br Med J i: 13\u201314, 1973","journal-title":"Br Med J"},{"key":"BF01806350_CR4","first-page":"38","volume":"67","author":"MJ O'Halloran","year":"1974","unstructured":"O'Halloran MJ, Maddock PG: ICI 46,474 in breast cancer. J Irish Med Assoc 67: 38\u201339, 1974","journal-title":"J Irish Med Assoc"},{"key":"BF01806350_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0305-7372(76)80010-2","volume":"3","author":"SS Legha","year":"1976","unstructured":"Legha SS, Carter SK: Antiestrogens in the treatment of breast cancer. Cancer Treat Rev 3: 205\u2013216, 1976","journal-title":"Cancer Treat Rev"},{"key":"BF01806350_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(84)90043-3","volume":"25","author":"BJA Furr","year":"1984","unstructured":"Furr BJA, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25: 127\u2013205, 1984","journal-title":"Pharmacol Ther"},{"key":"BF01806350_CR7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7326\/0003-4819-109-3-219","volume":"109","author":"SS Legha","year":"1988","unstructured":"Legha SS: Tamoxifen in the treatment of breast cancer. Ann Int Med 109: 219\u2013228, 1988","journal-title":"Ann Int Med"},{"key":"BF01806350_CR8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1200\/JCO.1989.7.6.803","volume":"7","author":"RR Love","year":"1989","unstructured":"Love RR: Tamoxifen therapy in primary breast cancer: Biology, efficacy and side effects. J Clin Oncol 7: 803\u2013815, 1989","journal-title":"J Clin Oncol"},{"key":"BF01806350_CR9","first-page":"3152","volume":"46","author":"CA Sawka","year":"1986","unstructured":"Sawka CA, Pritchard KI, Paterson DJA, Thomson DB, Skelley WE, Myers RE, Mobbs BG, Malkin A, Meakin JW: Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast cancer. Cancer Res 46: 3152\u20133156, 1986","journal-title":"Cancer Res"},{"key":"BF01806350_CR10","doi-asserted-by":"crossref","unstructured":"Ingle JN, Krook JE, Green SJ, Kubista TP, Everson LK, Ahman DL, Chang MN, Bisel HF, Windschitl HE, Twito DI, Pfeifle DM: Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer. J Clin Oncol 4178\u20134185, 1986","DOI":"10.1200\/JCO.1986.4.2.178"},{"key":"BF01806350_CR11","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1200\/JCO.1986.4.9.1326","volume":"4","author":"RB Buchanan","year":"1986","unstructured":"Buchanan RB, Blamey RW, Durrent KR, Howell A, Paterson AG, Preece PE, Smith DC, Williams CJ, Wilson RG: A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. J Clin Oncol 4: 1326\u20131330, 1986","journal-title":"J Clin Oncol"},{"key":"BF01806350_CR12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/bjc.1988.137","volume":"57","author":"Cancer Research Campaign Adjuvant Breast Trial Working Party","year":"1988","unstructured":"Cancer Research Campaign Adjuvant Breast Trial Working Party: Cyclophosphamide and tamoxifen as adjuvant therapy in the management of breast cancer. Br J Cancer 57: 604\u2013607, 1988","journal-title":"Br J Cancer"},{"key":"BF01806350_CR13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher B, Constantino J, Redmond C, and other members of the NSABP: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor-positive tumors. N Engl J Med 320: 479\u2013484, 1989","journal-title":"N Engl J Med"},{"key":"BF01806350_CR14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","volume":"319","author":"Early Breast Cancer Trialists' Collaborative Group","year":"1988","unstructured":"Early Breast Cancer Trialists' Collaborative Group: Effect of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 319: 1681\u20131692, 1988","journal-title":"N Engl J Med"},{"key":"BF01806350_CR15","first-page":"179","volume-title":"Important Advances in Oncology","author":"VC Jordan","year":"1989","unstructured":"Jordan VC: Long-term tamoxifen therapy for breast cancer.In: DeVita VT, Hellman S, Rosenberg S (eds): Important Advances in Oncology. Lippincott, Philadelphia, pp 179\u2013192, 1989"},{"key":"BF01806350_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-2964(75)90119-X","volume":"11","author":"VC Jordan","year":"1975","unstructured":"Jordan VC, Koerner S: Tamoxifen (ICI46,474) and the human carcinoma 8S estrogen receptor. Eur J Cancer 11: 205\u2013206, 1975","journal-title":"Eur J Cancer"},{"key":"BF01806350_CR17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1677\/joe.0.0520289","volume":"52","author":"JR Skidmore","year":"1972","unstructured":"Skidmore JR, Walpole AL, Woodburn J: Effect of some triphenylethylenes on oestradiol bindingin vitro to macromolecules from uterus and anterior pituitary. J Endocrinol 52: 289\u2013298, 1972","journal-title":"J Endocrinol"},{"key":"BF01806350_CR18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/256592a0","volume":"256","author":"ME Lippman","year":"1975","unstructured":"Lippman ME, Bolan G: Oestrogen-responsive human breast cancer in long-term tissue culture. Nature (Lond) 256: 592\u2013595, 1975","journal-title":"Nature (Lond)"},{"key":"BF01806350_CR19","first-page":"4618","volume":"43","author":"RR Reddel","year":"1983","unstructured":"Reddel RR, Murphy LC, Sutherland RL: Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cellsin vitro. Cancer Res 43: 4618\u20134624, 1983","journal-title":"Cancer Res"},{"key":"BF01806350_CR20","first-page":"1409","volume":"44","author":"CM Taylor","year":"1984","unstructured":"Taylor CM, Blanchard B, Zava DT: Estrogen receptor mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen. Cancer Res 44: 1409\u20131414, 1984","journal-title":"Cancer Res"},{"key":"BF01806350_CR21","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/jnci\/51.5.1409","volume":"51","author":"HD Soule","year":"1973","unstructured":"Soule HD, Vazquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409\u20131416, 1973","journal-title":"J Natl Cancer Inst"},{"key":"BF01806350_CR22","first-page":"3352","volume":"38","author":"LW Engel","year":"1978","unstructured":"Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 38: 3352\u20133364, 1978","journal-title":"Cancer Res"},{"key":"BF01806350_CR23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0014-2964(79)90139-7","volume":"15","author":"I Keydar","year":"1979","unstructured":"Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15: 659\u2013670, 1979","journal-title":"Eur J Cancer"},{"key":"BF01806350_CR24","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1073\/pnas.83.8.2496","volume":"83","author":"Y Berthois","year":"1986","unstructured":"Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS: Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496\u20132500. 1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01806350_CR25","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM198010093031511","volume":"303","author":"MB Sporn","year":"1980","unstructured":"Sporn MB, Todaro GJ: Autocrine secretion and malignant transformation of cells. N Engl J Med 303: 878\u2013880, 1980","journal-title":"N Engl J Med"},{"key":"BF01806350_CR26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1210\/endo-103-5-1742","volume":"103","author":"KB Horwitz","year":"1978","unstructured":"Horwitz KB, Koseki Y, McGuire WL: Estrogen control of progesterone receptor in human breast cancer: Role of estradiol and antiestrogen. Endocrinology 103: 1742\u20131751, 1978","journal-title":"Endocrinology"},{"key":"BF01806350_CR27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/mend-2-6-543","volume":"2","author":"SE Bates","year":"1988","unstructured":"Bates SE, Davidson NE, Vilverius EM, Freter CE, Dickson RB, Tam JP, Kudlow JE, Lippman ME, Saloman DS: Expression of transforming growth factor \u03b1 and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol 2: 543\u2013555, 1988","journal-title":"Mol Endocrinol"},{"key":"BF01806350_CR28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0092-8674(87)90193-0","volume":"48","author":"C Knabbe","year":"1987","unstructured":"Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB: Evidence that transforming growth factor-\u03b2 is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417\u2013428, 1987","journal-title":"Cell"},{"key":"BF01806350_CR29","first-page":"3898","volume":"48","author":"CL Arteaga","year":"1988","unstructured":"Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK: Transforming growth factor-\u03b2: Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48: 3898\u20133904, 1988","journal-title":"Cancer Res"},{"key":"BF01806350_CR30","first-page":"1758","volume":"49","author":"SP Robinson","year":"1989","unstructured":"Robinson SP, Jordan VC: Antiestrogenic action of toremifene on hormone dependent, independent and heterogeneous breast tumor growth in the athymic mouse. Cancer Res 49: 1758\u20131762, 1989","journal-title":"Cancer Res"},{"key":"BF01806350_CR31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.1972.tb00399.x","volume":"1","author":"Z El-Sheikha","year":"1972","unstructured":"El-Sheikha Z, Klopper A, Beck JS: Treatment of menometrorrhagia with an antioestrogen: Clin Endocrinol 1: 275\u2013282, 1972","journal-title":"Clin Endocrinol"},{"key":"BF01806350_CR32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/bmj.1.5741.152","volume":"i","author":"A Klopper","year":"1971","unstructured":"Klopper A, Hall M: New synthetic agent for the induction of ovulation: Preliminary trial in women. Brit Med J i: 152\u2013154, 1971","journal-title":"Brit Med J"},{"key":"BF01806350_CR33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1471-0528.1973.tb11230.x","volume":"80","author":"JG Williamson","year":"1973","unstructured":"Williamson JG, Ellis JD: The induction of ovulation by tamoxifen. J Obstet Gynaecol Brit Comm 80: 844\u2013847, 1973","journal-title":"J Obstet Gynaecol Brit Comm"},{"key":"BF01806350_CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01807278","volume":"11","author":"VC Jordan","year":"1988","unstructured":"Jordan VC: The development of tamoxifen for breast cancer therapy: A tribute to the late Arthur L. Walpole. Breast Cancer Res Treat 11: 197\u2013209, 1988","journal-title":"Walpole. Breast Cancer Res Treat"},{"key":"BF01806350_CR35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/189204a0","volume":"189","author":"C Huggins","year":"1961","unstructured":"Huggins C, Grand LC, Brillantes P: Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature (Lond) 189: 204\u2013207, 1961","journal-title":"Nature (Lond)"},{"key":"BF01806350_CR36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0022-4731(74)90388-4","volume":"5","author":"VC Jordan","year":"1974","unstructured":"Jordan VC: Antitumor activity of the antioestrogen ICI46,474 (tamoxifen) in the dimethylbenzanthracene (DMBA)-induced rat mammary carcinoma model. J Steroid Biochem 5: 354, 1974","journal-title":"J Steroid Biochem"},{"key":"BF01806350_CR37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0014-2964(76)90030-X","volume":"12","author":"VC Jordan","year":"1976","unstructured":"Jordan VC: Effect of tamoxifen (ICI46,474) on initiation and growth of DMBA-induced rat mammary carcinomata. Eur J Cancer 12: 419\u2013424, 1976","journal-title":"Eur J Cancer"},{"key":"BF01806350_CR38","unstructured":"Jordan VC: The antitumor effect of tamoxifen in the dimethylbenzanthracene-induced mammary carcinoma model. Proc Symposium on the Hormonal Control of Breast Cancer. Alderley Park, pp 11\u201317, ICI Pharmaceuticals Division PLC, Macclesfield, 1975"},{"key":"BF01806350_CR39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0014-2964(75)90129-2","volume":"11","author":"RI Nicholson","year":"1975","unstructured":"Nicholson RI, Golder MP: The effect of synthetic antioestrogens on the growth and biochemistry of rat mammary tumours. Eur J Cancer 11: 571\u2013579, 1975","journal-title":"Eur J Cancer"},{"key":"BF01806350_CR40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1677\/joe.0.0680297","volume":"68","author":"VC Jordan","year":"1976","unstructured":"Jordan VC, Dowse LJ: Tamoxifen as an antitumour agent: Effect on oestrogen binding. J Endocrinol 68: 297\u2013303, 1976","journal-title":"J Endocrinol"},{"key":"BF01806350_CR41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1677\/joe.0.0680305","volume":"68","author":"VC Jordan","year":"1976","unstructured":"Jordan VC, Koerner S: Tamoxifen as an antitumour agent: Role of oestradiol and prolactin. J Endocrinol 68: 305\u2013310, 1976","journal-title":"J Endocrinol"},{"key":"BF01806350_CR42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.0680453","volume":"68","author":"VC Jordan","year":"1976","unstructured":"Jordan VC, Jaspan T: Tamoxifen as an antitumour agent: Oestrogen binding as a predictive test for tumour response. J Endocrinol 68: 453\u2013460, 1976","journal-title":"J Endocrinol"},{"key":"BF01806350_CR43","first-page":"19","volume-title":"Adjuvant Therapy of Cancer II","author":"VC Jordan","year":"1979","unstructured":"Jordan VC, Dix CJ, Allen KE: The effectiveness of longterm treatment in a laboratory model for adjuvant hormone therapy of breast cancer.In, Salmon SE, Jones SE (eds) Adjuvant Therapy of Cancer II. Grune and Stratton, New York, pp 19\u201326, 1979"},{"key":"BF01806350_CR44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-2964(80)90156-5","volume":"16","author":"VC Jordan","year":"1980","unstructured":"Jordan VC, Allen KE: Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model. Eur J Cancer 16: 239\u2013251, 1980","journal-title":"Eur J Cancer"},{"key":"BF01806350_CR45","unstructured":"Jordan VC: Use of the DMBA-induced rat mammary carcinoma system for the evaluation of tamoxifen treatment as a potential adjuvant therapy. Rev Endocr Rel Cancer (Oct. Suppl): 49\u201355, 1978"},{"key":"BF01806350_CR46","first-page":"745","volume":"64","author":"VC Jordan","year":"1980","unstructured":"Jordan VC, Allen KE, Dix CJ: The pharmacology of tamoxifen in laboratory animals. Cancer Treat Rep 64: 745\u2013759, 1980","journal-title":"Cancer Treat Rep"},{"key":"BF01806350_CR47","first-page":"5386","volume":"47","author":"SP Robinson","year":"1987","unstructured":"Robinson SP, Jordan VC: The reversal of the antitumor effect of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model. Cancer Res 47: 5386\u20135390, 1987","journal-title":"Cancer Res"},{"key":"BF01806350_CR48","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/0277-5379(88)90091-0","volume":"24","author":"SP Robinson","year":"1988","unstructured":"Robinson SP, Mauel DA, Jordan VC: Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model. Eur J Cancer Clin Oncol 24: 1817\u20131821, 1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01806350_CR49","first-page":"401","volume":"54","author":"PM Gullino","year":"1975","unstructured":"Gullino PM, Pettigrew HM, Grantham FH: N-Nitrosomethylurea as a mammary carcinogen in rats. J Natl Cancer Inst 54: 401\u2013414, 1975","journal-title":"J Natl Cancer Inst"},{"key":"BF01806350_CR50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/bjs.1800690302","volume":"69","author":"AJ Wilson","year":"1982","unstructured":"Wilson AJ, Tehrani F, Baum M: Adjuvant tamoxifen therapy for early breast cancer: An experimental study with reference to oestrogen and progesterone receptors. Br J Surg 69: 121\u2013125, 1982","journal-title":"Br J Surg"},{"key":"BF01806350_CR51","first-page":"4020","volume":"47","author":"MM Gottardis","year":"1987","unstructured":"Gottardis MM, Jordan VC: The antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res 47: 4020\u20134024, 1987","journal-title":"Cancer Res"},{"key":"BF01806350_CR52","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/1097-0142(197811)42:5<2269::AID-CNCR2820420527>3.0.CO;2-F","volume":"42","author":"BC Giovanella","year":"1978","unstructured":"Giovanella BC, Stehlin JS, Williams LJ, Lee SS, Shepard RC: Heterotransplantation of human cancers into nude mice. Cancer 42: 2269\u20132281, 1978","journal-title":"Cancer"},{"key":"BF01806350_CR53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3835(80)90042-7","volume":"10","author":"HD Soule","year":"1980","unstructured":"Soule HD, McGrath CM: Estrogen proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett 10: 177\u2013189, 1980","journal-title":"Cancer Lett"},{"key":"BF01806350_CR54","first-page":"51","volume":"67","author":"SM Shafie","year":"1981","unstructured":"Shafie SM, Grantham FH: Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic mice. J Natl Cancer Inst 67: 51\u201356, 1981","journal-title":"J Natl Cancer Inst"},{"key":"BF01806350_CR55","first-page":"584","volume":"45","author":"CK Osborne","year":"1985","unstructured":"Osborne CK, Hobbs K, Clark GM: Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic mice. Cancer Res 45: 584\u2013590, 1985","journal-title":"Cancer Res"},{"key":"BF01806350_CR56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0022-4731(88)90113-6","volume":"30","author":"MM Gottardis","year":"1988","unstructured":"Gottardis MM, Robinson SP, Jordan VC: Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: A model to study the tumoristatic action of tamoxifen. J Steroid Biochem 30: 311\u2013314, 1988","journal-title":"J Steroid Biochem"},{"key":"BF01806350_CR57","doi-asserted-by":"crossref","unstructured":"Jordan VC, Gottardis MM, Robinson SP, Friedl A: Immune-deficient animals to study \u2018hormone-dependent\u2019 breast and endometrial cancer. J Steroid Biochem, 1989","DOI":"10.1016\/0022-4731(89)90079-4"},{"key":"BF01806350_CR58","unstructured":"Jordan VC, Iino Y, Langan-Fahey S, Ricchio M, Wolf DM: Reversible inhibition of oestradiol-stimulated breast cancer growth by the non-steroidal antioestrogen tamoxifen. Proc Brit Pharm Soc C127, London, Jan 3\u20135, 1990"},{"key":"BF01806350_CR59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/07357908809082124","volume":"6","author":"VC Jordan","year":"1988","unstructured":"Jordan VC: Chemosuppression of breast cancer with tamoxifen: Laboratory evidence and future clinical investigations. Cancer Invest 6: 5\u201311, 1988","journal-title":"Cancer Invest"},{"key":"BF01806350_CR60","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0277-5379(87)90154-4","volume":"23","author":"CK Osborne","year":"1987","unstructured":"Osborne CK, Coronado EB, Robinson JP: Human breast cancer in the athymic nude mouse: Cytostatic effects of long-term antiestrogen therapy. Eur J Cancer Clin Oncol 23: 1189\u20131196, 1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01806350_CR61","first-page":"5183","volume":"48","author":"MM Gottardis","year":"1988","unstructured":"Gottardis MM, Jordan VC: Development of tamoxifenstimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res 48: 5183\u20135187, 1988","journal-title":"Cancer Res"},{"key":"BF01806350_CR62","first-page":"4090","volume":"49","author":"MM Gottardis","year":"1989","unstructured":"Gottardis MM, Jiang SY, Jeng MH, Jordan VC: Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens. Cancer Res 49: 4090\u20134093, 1989","journal-title":"Cancer Res"},{"key":"BF01806350_CR63","first-page":"4765","volume":"49","author":"MM Gottardis","year":"1989","unstructured":"Gottardis MM, Wagner RJ, Borden EC, Jordan VC: Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growthin vivo andin vitro. Cancer Res 49: 4765\u20134769, 1989","journal-title":"Cancer Res"},{"key":"BF01806350_CR64","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1677\/joe.0.112R007","volume":"112","author":"AE Wakeling","year":"1987","unstructured":"Wakeling AE, Bowler J: Steroidal pure antioestrogens. J Endocrinol 112: R7-R10, 1987","journal-title":"J Endocrinol"},{"issue":"Suppl","key":"BF01806350_CR65","first-page":"3437s","volume":"42","author":"RML Murray","year":"1982","unstructured":"Murray RML, Pitt P: Aminoglutethimide in tamoxifenresistant patients: The Melbourne experience. Cancer Res 42 (Suppl): 3437s-3441s, 1982","journal-title":"Cancer Res"},{"key":"BF01806350_CR66","first-page":"133","volume-title":"Breast Cancer Management Early and Late","author":"BA Stoll","year":"1977","unstructured":"Stoll BA: Palliation by castration or by hormone administration.In: Stoll BA (ed) Breast Cancer Management Early and Late. W. Heinemann Medical Books Ltd, London, pp 133\u2013146, 1977"},{"key":"BF01806350_CR67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01806449","volume":"2","author":"VC Jordan","year":"1982","unstructured":"Jordan VC: Metabolites of tamoxifen in animals and man: Identification, pharmacology and significance. Breast Cancer Res Treat 2: 123\u2013138, 1982","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806350_CR68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0006-2952(79)90283-1","volume":"27","author":"HK Adam","year":"1979","unstructured":"Adam HK, Douglas EJ, Kemp JV: The metabolism of tamoxifen in humans. Biochem Pharmacol 27: 145\u2013147, 1979","journal-title":"Biochem Pharmacol"},{"key":"BF01806350_CR69","first-page":"1446","volume":"43","author":"VC Jordan","year":"1983","unstructured":"Jordan VC, Bain RR, Brown RR, Gosden B, Santos MA: Determination and pharmacology of a new hydroxylated metabolite of tamoxifen observed in patient sera during therapy for advanced breast cancer. Cancer Res 43: 1446\u20131450, 1983","journal-title":"Cancer Res"},{"key":"BF01806350_CR70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1677\/joe.0.0750305","volume":"75","author":"VC Jordan","year":"1977","unstructured":"Jordan VC, Collins MM, Rowsby L, Prestwich G: A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J Endocrinol 75: 305\u2013316, 1977","journal-title":"J Endocrinol"},{"key":"BF01806350_CR71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/15287397809529666","volume":"4","author":"VC Jordan","year":"1978","unstructured":"Jordan VC, Dix CJ, Naylor KE, Prestwich G, Rowsby L: Non-steroidal antioestrogens: Their biological effects and potential mechanisms of action. J Toxicol Environ Health 4: 364\u2013390, 1978","journal-title":"J Toxicol Environ Health"},{"key":"BF01806350_CR72","first-page":"317","volume":"42","author":"E Coezy","year":"1982","unstructured":"Coezy E, Borgna JL, Rochefort H: Tamoxifen and metabolites in MCF-7 cells and correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 42: 317\u2013323, 1982","journal-title":"Cancer Res"},{"key":"BF01806350_CR73","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01806042","volume":"4","author":"DC Tormey","year":"1984","unstructured":"Tormey DC, Jordan VC: Long-term tamoxifen adjuvant therapy in node-positive breast cancer: A metabolic and pilot clinical study. Breast Cancer Res Treat 4: 297\u2013302, 1984","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806350_CR74","unstructured":"Falkson HC, Gray R, Wolberg WM: Adjuvant therapy of postmenopausal women with breast cancer \u2014 an ECOG Phase III study. Abstract 67, ASCO San Francisco, May, 1989"},{"key":"BF01806350_CR75","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-106-5-649","volume":"106","author":"B Fisher","year":"1987","unstructured":"Fisher B, and other NSABP Investigators: Prolonging tamoxifen for primary breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project Clinical Trial. Ann Int Med 106: 649\u2013654, 1987","journal-title":"Ann Int Med"},{"key":"BF01806350_CR76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01806795","volume":"7","author":"T Delozier","year":"1986","unstructured":"Delozier T, Julien JP, Juret P, Veyret C, Couette JE, Grai Y, Olliver JM, deRanieri E: Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial. Breast Cancer Res Treat 7: 105\u2013110, 1986","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806350_CR77","first-page":"171","volume":"ii","author":"Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC)","year":"1987","unstructured":"Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC): Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial. Lancet ii: 171\u2013175, 1987","journal-title":"Lancet"},{"key":"BF01806350_CR78","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0002-9378(87)90170-0","volume":"156","author":"MI Whitehead","year":"1987","unstructured":"Whitehead MI, Fraser D: Controversies concerning the safety of estrogen replacement therapy. Am J Obstet Gynecol 156: 1313\u20131322, 1987","journal-title":"Am J Obstet Gynecol"},{"key":"BF01806350_CR79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jbmr.5650020513","volume":"2","author":"RT Turner","year":"1987","unstructured":"Turner RT, Wakeley GK, Hannon KS, Bell NA: Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J Bone Min Res 2: 449\u2013456, 1987","journal-title":"J Bone Min Res"},{"key":"BF01806350_CR80","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/endo-122-3-1146","volume":"122","author":"RT Turner","year":"1988","unstructured":"Turner RT, Wakeley GK, Hannon KS, Bell NH: Tamoxifen inhibits osteoclast mediated resorption of trabecular bone in ovarian hormone deficient rats. Endocrinology 122: 1146\u20131150, 1988","journal-title":"Endocrinology"},{"key":"BF01806350_CR81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01806132","volume":"10","author":"VC Jordan","year":"1987","unstructured":"Jordan VC, Phelps E, Lingren JU: Effects of antiestrogens on bone in castrated and intact female rats. Breast Cancer Res Treat 10: 31\u201335, 1987","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806350_CR82","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01811242","volume":"12","author":"RR Love","year":"1988","unstructured":"Love RR, Mazess RB, Tormey DC, Barden HS, Newcomb PA, Jordan VC: Bone mineral density in women with breast cancer treated for at least two years with tamoxifen. Breast Cancer Res Treat 12: 297\u2013301, 1988","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806350_CR83","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jnci\/81.14.1086","volume":"81","author":"S Turken","year":"1989","unstructured":"Turken S, Siris E, Seldin E, Seldin D, Flaster E, Hyman G, Lindsay R: Effects of tamoxifen on spinal bone density in women with breast cancer. J Natl Cancer Inst 81: 1086\u20131088, 1989","journal-title":"J Natl Cancer Inst"},{"key":"BF01806350_CR84","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0021-9150(84)90064-9","volume":"52","author":"S Rossner","year":"1984","unstructured":"Rossner S, Wallgren A: Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis 52: 339\u2013346, 1984","journal-title":"Atherosclerosis"},{"key":"BF01806350_CR85","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01811244","volume":"12","author":"G Bertelli","year":"1988","unstructured":"Bertelli G, Pronzoto P, Amoroso D: Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levels. Breast Cancer Res Treat 12: 307\u2013310, 1988","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806350_CR86","unstructured":"Love RR, Newcomb PA, Wiebe DA, Surawicz TS, Jordan VC, Carbone PP, DeMets DC: Lipid and lipoprotein effects of tamoxifen therapy in postmenopausal women with node negative breast cancer. Breast Cancer Res Treat abstract 204, 1989"},{"key":"BF01806350_CR87","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/bjc.1988.122","volume":"57","author":"I Smith","year":"1988","unstructured":"Smith I: Adjuvant tamoxifen for early breast cancer. Br J Cancer 57: 527\u2013528, 1988","journal-title":"Br J Cancer"},{"key":"BF01806350_CR88","first-page":"624","volume":"47","author":"VC Jordan","year":"1987","unstructured":"Jordan VC, Fritz NF, Tormey DC: Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node positive patients with breast cancer. Cancer Res 47: 624\u2013630, 1987","journal-title":"Cancer Res"},{"key":"BF01806350_CR89","first-page":"4517","volume":"47","author":"VC Jordan","year":"1987","unstructured":"Jordan VC, Fritz NF, Tormey DC: Long-term adjuvant therapy with tamoxifen: Effects on sex hormone binding globulin and antithrombin III. Cancer Res 47: 4517\u20134519, 1987","journal-title":"Cancer Res"},{"key":"BF01806350_CR90","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/acta.0.0970109","volume":"97","author":"G Fex","year":"1981","unstructured":"Fex G, Adielson G, Mattson W: Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. Acta Endocrinol Copen 97: 109\u2013113, 1981","journal-title":"Acta Endocrinol Copen"},{"key":"BF01806350_CR91","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000225571","volume":"38","author":"F Boccardo","year":"1981","unstructured":"Boccardo F, Buzzi L, Ruboyotti A, Nicolo G, Rosso R: Oestrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 38: 281\u2013285, 1981","journal-title":"Oncology"},{"key":"BF01806350_CR92","first-page":"3680","volume":"40","author":"JD Yager","year":"1980","unstructured":"Yager JD, Yager R: Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 40: 3680\u20133685, 1980","journal-title":"Cancer Res"},{"key":"BF01806350_CR93","unstructured":"Gau T. Stuart Pharmaceuticals, A division of ICI Americas, Wilmington, Delaware. Open letter to all US medical oncologists describing the toxicological findings in rats with high dose tamoxifen treatment, 1986"},{"key":"BF01806350_CR94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0344-0338(84)80055-2","volume":"179","author":"H Fox","year":"1984","unstructured":"Fox H: Endometrial carcinogenesis and its relation to oestrogens. Path Res Pract 179: 13\u201319, 1984","journal-title":"Path Res Pract"},{"key":"BF01806350_CR95","first-page":"805","volume":"64","author":"KD Swenerton","year":"1980","unstructured":"Swenerton KD: Treatment of advanced endometrial adenocarcinoma with tamoxifen. Cancer Treat Rep 64: 805\u2013811, 1980","journal-title":"Cancer Treat Rep"},{"key":"BF01806350_CR96","first-page":"4006","volume":"44","author":"PG Satyaswaroop","year":"1984","unstructured":"Satyaswaroop PG, Zaino RJ, Mortel R: Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 44: 4006\u20134010, 1984","journal-title":"Cancer Res"},{"key":"BF01806350_CR97","first-page":"237","volume":"69","author":"MA Killackey","year":"1985","unstructured":"Killackey MA, Hakes TB, Pierce VK: Endometrial adenocarcinoma in breast cancer patients receiving tamoxifen. Cancer Treat Rep 69: 237\u2013238, 1985","journal-title":"Cancer Treat Rep"},{"key":"BF01806350_CR98","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(88)92675-X","volume":"ii","author":"L Hardell","year":"1988","unstructured":"Hardell L: Tamoxifen as risk factor for carcinoma of corpus uteri. Lancet ii: 563, 1988","journal-title":"Lancet"},{"key":"BF01806350_CR99","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(88)90629-0","volume":"ii","author":"L Hardell","year":"1988","unstructured":"Hardell L: Pelvic irradiation and tamoxifen as risk factors for carcinoma of corpus uteri. Lancet ii: 1432, 1988","journal-title":"Lancet"},{"key":"BF01806350_CR100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","volume":"i","author":"T Fornander","year":"1989","unstructured":"Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattson A, Silversward JC, Skoog L, Somell A, Theve T, Wilking N, Askergren J, Hjolmar ML: Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet i: 117\u2013120, 1989","journal-title":"Lancet"},{"key":"BF01806350_CR101","first-page":"375","volume":"i","author":"HJ Stewart","year":"1989","unstructured":"Stewart HJ, Knight GM: Tamoxifen and the uterus and endometrium. Lancet i: 375\u2013376, 1989","journal-title":"Lancet"},{"key":"BF01806350_CR102","first-page":"812","volume":"48","author":"MM Gottardis","year":"1988","unstructured":"Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC: Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 48: 812\u2013815, 1988","journal-title":"Cancer Res"},{"key":"BF01806350_CR103","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1677\/joe.0.0700421","volume":"70","author":"GV Groom","year":"1976","unstructured":"Groom GV, Griffiths K: Effect of the antioestrogen tamoxifen on plasma levels of luteinizing hormone, folliclestimulating hormone, prolactin, oestradiol and progesterone in normal premenopausal women. J Endocrinol 70: 421\u2013428, 1976","journal-title":"J Endocrinol"},{"key":"BF01806350_CR104","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(16)47172-4","volume":"40","author":"C Tajima","year":"1983","unstructured":"Tajima C, Fukushima T: Endocrine profile in tamoxifeninduced ovulatory cycles. Fert Steril 40: 23\u201327, 1983","journal-title":"Fert Steril"},{"key":"BF01806350_CR105","first-page":"1026","volume":"48","author":"PM Ravdin","year":"1988","unstructured":"Ravdin PM, Fritz NF, Tormey DC, Jordan VC: Endocrine status of premenopausal node positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. Cancer Res 48: 1026\u20131029, 1988","journal-title":"Cancer Res"},{"key":"BF01806350_CR106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0022-4731(84)90199-7","volume":"20","author":"RI Nicholson","year":"1984","unstructured":"Nicholson RI, Walker KJ, Turkes A, Turkes AO, Dyas J, Blamey RW, Cambell FC, Robinson MRG, Griffiths K: Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118,630 in breast cancer and prostate cancer. J Steroid Biochem 20: 129\u2013135, 1984","journal-title":"J Steroid Biochem"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806350\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:43:54Z","timestamp":1557402234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["BF01806350"],"URL":"https:\/\/doi.org\/10.1007\/bf01806350","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}